federal_register: 2022-01928
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01928 | Removal of Certain Requirements Related to the Prescription Drug Marketing Act; Opportunity for Public Comment; Withdrawal | Proposed Rule | The Food and Drug Administration (FDA, the Agency, or we) is announcing the withdrawal of the proposed rule "Removal of Certain Requirements Related to the Prescription Drug Marketing Act; Opportunity for Public Comment," published in the Federal Register on July 14, 2011. FDA is taking this action because the proposed changes are duplicative of another FDA proposed rulemaking, which is also being published in this issue of the Federal Register, that is intended to conform with newly established definitions and requirements set out by the Drug Supply Chain Security Act of 2013 (DSCSA). | 2022-02-04 | 2022 | 2 | https://www.federalregister.gov/documents/2022/02/04/2022-01928/removal-of-certain-requirements-related-to-the-prescription-drug-marketing-act-opportunity-for | https://www.govinfo.gov/content/pkg/FR-2022-02-04/pdf/2022-01928.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA, the Agency, or we) is announcing the withdrawal of the proposed rule "Removal of Certain Requirements Related to the Prescription Drug Marketing Act; Opportunity for Public Comment," published in the Federal... |